Page 3 - Abrocitinib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abrocitinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abrocitinib Today - Breaking & Trending Today

Pfizer Abrocitinib for atopic dermatitis approved in Japan

Published: October 3, 2021

New York: Pfizer Inc. has recently announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved CIBINQO (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor,...

Source: medicaldialogues.in

Related Topics:

United StatesUnited KingdomGreat BritainAngela HwangJapanese Ministry Of HealthEuropean UnionPfizer Biopharmaceuticals GroupRegulatory AgencyGroup PresidentPfizer BiopharmaceuticalsJapanese MinistryUnited Kingdom MedicinesPfizer NewsAtopic Dermatitis